GC–MS and HPLC analysis of antiglycogenolytic and glycogenic compounds in kaempferol 3–O–gentiobioside containing Senna alata L leaves in experimental rats

S. Mohanasundaram , N. Rangarajan , V. Sampath , K. Porkodi , M. Pennarasi
{"title":"GC–MS and HPLC analysis of antiglycogenolytic and glycogenic compounds in kaempferol 3–O–gentiobioside containing Senna alata L leaves in experimental rats","authors":"S. Mohanasundaram ,&nbsp;N. Rangarajan ,&nbsp;V. Sampath ,&nbsp;K. Porkodi ,&nbsp;M. Pennarasi","doi":"10.1016/j.tmsr.2021.07.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Medicinal herbs have received attention as an alternative to prescription medications. Diabetes mellitus is a chronic disease that affects the normal metabolic pathways in several organs. The purpose of this study was to determine the metabolites responsible for the antiglycogenolytic and glycogenic effects of a hydroethanolic extract of <em>Senna alata</em> L in an experimental model of diabetes mellitus; the male albino Wister rat treated with streptozotocin.</p></div><div><h3>Results</h3><p>The therapeutic effects of Glibenclamide (0.6 mg/kg body weight) and <em>S. alata</em> L (400 mg/kg body weight) extracts were compared. The oral administration of this extract to diabetic rats resulted in a significant decrease in the levels of glycogenolytic factors that included: glycogen phosphorylase, glucose 6 phosphatase, glycosylated haemoglobin, and lactate dehydrogenase, and a significant increase in the levels of glycogenic factors such as plasma insulin, glycogen synthase, liver glycogen, hexokinase, pyruvate kinase After administration of the plant extract, the observed changes in the activities of these factors were found to be statistically significant and returned to near-normal levels. Additionally, the <em>S. alata</em> extract increased muscle and liver glycogen levels, demonstrating <em>S. alata</em> L's anti-diabetic properties. HPLC analysis identified Kaempferol 3–O–gentiobioside, while GCMS analysis showed the presence of phytol, stigmasterol, sitosterol, dimethyl derivatives, methyl esters, and octanoic acid derivatives.</p></div><div><h3>Conclusion</h3><p>This work provides experimental evidence for the anti-diabetic potential of <em>S. alata</em> extract, which may result from the existence of beneficial bioactive chemicals. The aberrant metabolic enzymes in streptozotocin-induced diabetic rats' livers were restored following regular treatment with <em>S. alata</em> extract. As a result, <em>S. alata</em> leaves can affect blood glucose levels.</p></div>","PeriodicalId":23223,"journal":{"name":"Translational Metabolic Syndrome Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.tmsr.2021.07.001","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Metabolic Syndrome Research","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2588930321000025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Background

Medicinal herbs have received attention as an alternative to prescription medications. Diabetes mellitus is a chronic disease that affects the normal metabolic pathways in several organs. The purpose of this study was to determine the metabolites responsible for the antiglycogenolytic and glycogenic effects of a hydroethanolic extract of Senna alata L in an experimental model of diabetes mellitus; the male albino Wister rat treated with streptozotocin.

Results

The therapeutic effects of Glibenclamide (0.6 mg/kg body weight) and S. alata L (400 mg/kg body weight) extracts were compared. The oral administration of this extract to diabetic rats resulted in a significant decrease in the levels of glycogenolytic factors that included: glycogen phosphorylase, glucose 6 phosphatase, glycosylated haemoglobin, and lactate dehydrogenase, and a significant increase in the levels of glycogenic factors such as plasma insulin, glycogen synthase, liver glycogen, hexokinase, pyruvate kinase After administration of the plant extract, the observed changes in the activities of these factors were found to be statistically significant and returned to near-normal levels. Additionally, the S. alata extract increased muscle and liver glycogen levels, demonstrating S. alata L's anti-diabetic properties. HPLC analysis identified Kaempferol 3–O–gentiobioside, while GCMS analysis showed the presence of phytol, stigmasterol, sitosterol, dimethyl derivatives, methyl esters, and octanoic acid derivatives.

Conclusion

This work provides experimental evidence for the anti-diabetic potential of S. alata extract, which may result from the existence of beneficial bioactive chemicals. The aberrant metabolic enzymes in streptozotocin-induced diabetic rats' livers were restored following regular treatment with S. alata extract. As a result, S. alata leaves can affect blood glucose levels.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
参叶山奈酚3 - o -龙胆皂苷实验大鼠抗糖原和糖原化合物的GC-MS和HPLC分析
草药作为处方药的替代品已经受到了人们的关注。糖尿病是一种影响多个器官正常代谢途径的慢性疾病。本研究的目的是在糖尿病实验模型中确定参天泻泻水乙醇提取物抗糖原和糖原作用的代谢物;用链脲佐菌素治疗雄性白化Wister大鼠。结果比较了格列本脲(0.6 mg/kg体重)和白荆(400 mg/kg体重)提取物的治疗效果。糖尿病大鼠口服该提取物可显著降低糖原溶解因子的水平,这些因子包括:糖原磷酸化酶、葡萄糖6磷酸酶、糖基化血红蛋白、乳酸脱氢酶,血浆胰岛素、糖原合成酶、肝糖原、己糖激酶、丙酮酸激酶等糖原因子水平显著升高。服用植物提取物后,观察到这些因子活性的变化具有统计学意义,并恢复到接近正常水平。此外,阿拉木图提取物增加肌肉和肝糖原水平,证明阿拉木图的抗糖尿病特性。HPLC分析鉴定出山奈酚3-O-gentiobioside, GCMS分析鉴定出叶绿醇、豆甾醇、谷甾醇、二甲基衍生物、甲酯和辛酸衍生物。结论乌桕提取物具有一定的抗糖尿病作用,可能与乌桕中存在有益的生物活性物质有关。通过对糖尿病大鼠进行常规治疗,可以恢复其肝脏代谢酶的异常。因此,阿拉木图叶子可以影响血糖水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Review of the methods to measure non-adherence with a focus on chemical adherence testing Glycome assessment in patients with respiratory diseases The role of IgG N-galactosylation in spondyloarthritis Semaglutide is precipitating a revolution in obesity care The efficacy of dairy products fortified with nano-encapsulated vitamin D3 on physical and mental aspects of the health in obese subjects; the protocol of the SUVINA trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1